U.S. Generic Pharmaceuticals Outlook


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research service provides an outlook of the U.S. generic pharmaceuticals market and includes the unbranded generic drugs sold within the U.S. The research service provides a market overview, trends, competitive landscape, market forecasts, market share analysis, industry challenges and opportunities.

Table of Contents

U.S. Generic Pharmaceuticals Outlook, Executive SummaryExecutive SummaryExecutive SummaryU.S. Generic Pharmaceuticals Outlook, U.S. Generic Pharmaceuticals MarketMarket OverviewIntroductionScope and SegmentationResearch MethodologyMarket DynamicsMarket Engineering MeasurementsMarket TrendsFinancial SnapshotMarket ForecastsPrescription ForecastsRevenue ForecastsCompetitive LandscapeCompetitive StructurePipeline AnalysisMarket Share AnalysisChallenges and OpportunitiesIndustry ChallengesOpportunitiesU.S. Generic Pharmaceuticals Outlook, Decision Support DatabasesDemographic IndicatorTotal PopulationMarket IndicatorsGovernment Healthcare ExpenditurePrivate Healthcare ExpenditurePharmaceutical R&D ExpenditurePercent Pharmaceutical R&D ExpenditureNumber of Hospitals

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.